Mark Hertzberg
Impact in
- Hematology top 0.5%
- Platelet Disorders and Treatments
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 65
- Hematology 66
- Hematopoietic Stem Cell Transplantation 21
- Acute Myeloid Leukemia Research 15
- Platelet Disorders and Treatments 14
- Chronic Myeloid Leukemia Treatments 14
- Co-authors
- David Gottlieb (26 shared papers)Emmanuel J. Favaloro (18 shared papers)Ian Kerridge (24 shared papers)Matthew J. Matasar (9 shared papers)Andrew McMillan (9 shared papers)Christopher R. Flowers (9 shared papers)Laurie H. Sehn (11 shared papers)Alex F. Herrera (9 shared papers)
- Journals
- Blood (42 papers)Journal of Clinical Oncology (16 papers)Bone Marrow Transplantation (7 papers)Biology of Blood and Marrow Transplantation (5 papers)Hematological Oncology (4 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark Hertzberg
157 papers receiving 3.6k citations
Mark Hertzberg's Hit Papers
Peers
Comparison fields: 5 of 104
- Hematology 1.0k
- Pathology and Forensic Medicine 1.4k
- Genetics 767
- Oncology 1.5k
- Immunology 568
Countries citing papers authored by Mark Hertzberg
This map shows the geographic impact of Mark Hertzberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hertzberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hertzberg more than expected).
Fields of papers citing papers by Mark Hertzberg
This network shows the impact of papers produced by Mark Hertzberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hertzberg. The network helps show where Mark Hertzberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Hertzberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 168 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Hit paper breakdown → | 2019 | 477 |
| 2 | Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study Hit paper breakdown → | 2014 | 430 |
| 3 | 2018 | 235 | |
| 4 | 2018 | 150 | |
| 5 | 2010 | 135 | |
| 6 | 2013 | 121 | |
| 7 | 2021 | 113 | |
| 8 | 2014 | 101 | |
| 9 | 2015 | 67 | |
| 10 | 2000 | 59 | |
| 11 | 2018 | 57 | |
| 12 | 1999 | 54 | |
| 13 | 2001 | 50 | |
| 14 | 2016 | 46 | |
| 15 | 2012 | 44 | |
| 16 | 1994 | 43 | |
| 17 | 2011 | 42 | |
| 18 | 2019 | 40 | |
| 19 | 2018 | 38 | |
| 20 | 2002 | 36 |
About Mark Hertzberg
Mark Hertzberg is a scholar working on Pathology and Forensic Medicine, Hematology, Oncology, Genetics and Epidemiology, having authored 168 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (65 papers), Chronic Lymphocytic Leukemia Research (36 papers), Hematopoietic Stem Cell Transplantation (21 papers), CAR-T cell therapy research (17 papers), Acute Myeloid Leukemia Research (15 papers), Platelet Disorders and Treatments (14 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Viral-associated cancers and disorders (13 papers). The work is most often cited by research in Hematology (1.0k citations), Pathology and Forensic Medicine (1.4k citations), Genetics (767 citations), Oncology (1.5k citations) and Immunology (568 citations). Mark Hertzberg has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include David Gottlieb, Emmanuel J. Favaloro, Ian Kerridge, Matthew J. Matasar, Andrew McMillan, Christopher R. Flowers, Laurie H. Sehn, Alex F. Herrera, Tae Min Kim and Grace Ku. Their work appears in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.